Delivery Order SPE2DB22D1106-SPE2DB25FEWP1
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $9,218.58 and a period of performance through July 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication, with a ceiling value of $1,526.34 and a performance period through July 10, 2025. The contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $5,664.46 and a period of performance through July 8, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a ceiling value of $1,017.58 and a performance period through June 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a ceiling value of $11,150.36 and a completion date of June 16, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the medication AIMOVIG 140 MG/ML AUTOINJECTORML, with a ceiling value of $2,543.90 and a period of performance through May 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML. The contract has a ceiling value of $6,104.76 and a period of performance through June 18, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication. The contract has a ceiling value of $6,105.36 and a performance period through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,612.79 and a period of performance through January 27, 2025. The contract was not set aside for any specific business type....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $1,017.58 and a performance period ending on June 24, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEWP1Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a ceiling value of $8,316.75 and a performance period ending on July 8, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/7/25 |